A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase I-II multicenter clinical trial is to establish dosimetry and
safety profiles for CARDIOLITE® (Technetium Tc99m Sestamibi) in pediatric subjects.